Price
Target price
€15.60
€15.60
-0.640%
-0.1
-0.640%
€18.53
31.05.24 / Tradegate
WKN: 883035 / Symbol: TEVA / Name: Teva Pharma / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Teva Pharmaceutical Industries Ltd ADR Stock
The price for the Teva Pharmaceutical Industries Ltd ADR stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.640%).
With 13 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 18 € there is a slightly positive potential of 15.38% for Teva Pharmaceutical Industries Ltd ADR compared to the current price of 15.6 €.
Our community identified positive and negative aspects for Teva Pharmaceutical Industries Ltd ADR stock for the coming years. 2 users see the criterium "Management" as a plus for the Teva Pharmaceutical Industries Ltd ADR stock. On the other hand our users think that "Conscious of the environment" could be a problem in the future.
Pros and Cons of Teva Pharmaceutical Industries Ltd ADR in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Teva Pharmaceutical Industries Ltd ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd ADR | -0.640% | 1.961% | 18.182% | 131.454% | 67.382% | 79.724% | 101.031% |
Bayer AG ADR | -6.430% | -2.963% | -0.758% | -50.000% | -23.837% | -50.000% | -50.000% |
Roche Holding AG ADR | 1.620% | 1.262% | 5.554% | -20.397% | -8.789% | -17.553% | - |
GSK plc ADR | 1.470% | -0.481% | 8.377% | 31.013% | 23.214% | 3.500% | -4.277% |
Comments
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Bank of America Co. from $18.00 to $21.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $20.00 price target on the stock, up previously from $19.00.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $17.00 to $20.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat